European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Cabazitaxel Accord, cabazitaxel, Date of authorisation: 28/08/2020, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 7 January 2026 - 16:20

Human medicines European public assessment report (EPAR): Cabazitaxel Accord, cabazitaxel, Date of authorisation: 28/08/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Olanzapine Viatris (previously Olanzapine Mylan), olanzapine, Date of authorisation: 06/10/2008, Revision: 23, Status: Authorised

Submitted by Anonymous (not verified) on 7 January 2026 - 16:10

Human medicines European public assessment report (EPAR): Olanzapine Viatris (previously Olanzapine Mylan), olanzapine, Date of authorisation: 06/10/2008, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date of authorisation: 21/02/2006, Revision: 45, Status: Authorised

Submitted by Anonymous (not verified) on 7 January 2026 - 16:10

Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date of authorisation: 21/02/2006, Revision: 45, Status: Authorised

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised

Submitted by Anonymous (not verified) on 7 January 2026 - 16:05

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 7 January 2026 - 16:02

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Norvir, ritonavir, Date of authorisation: 25/08/1996, Revision: 72, Status: Authorised

Submitted by Anonymous (not verified) on 7 January 2026 - 15:58

Human medicines European public assessment report (EPAR): Norvir, ritonavir, Date of authorisation: 25/08/1996, Revision: 72, Status: Authorised

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 46, Status: Authorised

Submitted by Anonymous (not verified) on 7 January 2026 - 15:45

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 46, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness